| Quarterly Financials | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 |
Revenue  | 492 | 588 | 593 | 533 | 627 | 695 | 706 | 732 | 795 | 865 | 855 | 836 | 883 | 975 | 960 | 954 |
| Expenses | 386 | 442 | 448 | 441 | 485 | 523 | 534 | 540 | 595 | 631 | 621 | 629 | 675 | 728 | 706 | 757 |
| EBITDA | 106 | 146 | 146 | 92 | 142 | 172 | 172 | 192 | 199 | 234 | 234 | 207 | 208 | 247 | 254 | 198 |
| Operating Profit % | 21 % | 24 % | 23 % | 15 % | 21 % | 23 % | 23 % | 24 % | 24 % | 25 % | 26 % | 22 % | 22 % | 24 % | 25 % | 19 % |
| Depreciation | 31 | 31 | 33 | 35 | 36 | 37 | 39 | 38 | 40 | 43 | 44 | 46 | 47 | 49 | 49 | 49 |
| Interest | 16 | 17 | 18 | 28 | 19 | 18 | 21 | 21 | 18 | 20 | 18 | 18 | 18 | 16 | 16 | 15 |
| Profit Before Tax | 58 | 98 | 95 | 29 | 87 | 117 | 112 | 133 | 141 | 171 | 172 | 143 | 144 | 181 | 189 | 133 |
| Tax | 16 | 31 | 25 | 12 | 28 | 31 | 32 | 32 | 39 | 45 | 49 | 16 | 37 | 50 | 46 | 32 |
| Net Profit | 42 | 67 | 70 | 18 | 59 | 86 | 81 | 101 | 102 | 125 | 124 | 127 | 106 | 131 | 143 | 101 |
| EPS in ₹ | 5.13 | 13.22 | 2.76 | 0.69 | 2.32 | 3.38 | 3.08 | 3.77 | 3.80 | 4.66 | 4.61 | 4.74 | 3.96 | 4.87 | 5.32 | 3.77 |
Global Health
Global Health
1,331.40
-24.00
(-1.77%)
Market Cap
36,404.30 Cr
EPS
17.92
PE Ratio
70.04
Dividend Yield
0.04 %
Industry
Healthcare Services52 Week High
1,393.20
52 Week Low
935.50
PB Ratio
10.72
Debt to Equity
0.36
Sector
Hospitals
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from11 analysts
Company News
View All News
Global Health Limited Schedules Board Meeting on August 7 to Approve Quarterly Financial ResultsToday
Global Health Limited has scheduled a Board of Directors meeting on August 7, 2025, to consider and approve the unaudited financial results for the quarter ended June 30, 2025. The company's trading window is closed from July 1, 2025, and will reopen 48 hours after the results declaration. The company trades on BSE with scrip code 543654 and on NSE with symbol MEDANTA.
Global Health Limited (Medanta) has received approval from the Assam Cabinet for allotment of 3.5 acres of land on long-term lease for a hospital project in Guwahati. The lease terms include a 60-year duration with an option for 30-year renewal, requiring an upfront land lease charge of Rs. 56 crore and ongoing estate charges of Rs. 2.42 per square meter per month. This 3.5-acre land allocation replaces an earlier offer of 3 acres from Assam Electricity Grid Corporation Limited, following the company's request for substitution with suitable highway-adjacent land. The Cabinet also approved a common Floor Area Ratio (FAR) for the entire land parcel comprising two hospitals and one hotel. Medanta is awaiting further details from relevant agencies and will proceed with execution of agreements.
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,274.30 | #1 1,22,237.70 | 108.01 | 7,184.10 | 18.77 | 1,076 | 26.84 | 53.37 | |
7,456.00 | 1,05,775.20 | 73.16 | #1 21,794.00 | 14.74 | 1,513 | 60.41 | 53.50 | |
850.60 | 63,888.30 | 75.79 | 7,849.70 | 8.99 | 809 | -7.43 | 69.85 | |
1,987.00 | 40,694.40 | 51.05 | 5,482.98 | 10.96 | 807 | 3.41 | 53.22 | |
1,331.40 | #5 36,404.30 | #4 70.04 | #6 3,692.32 | #1 25.09 | #6 486 | #9 -20.35 | 70.28 | |
749.85 | 30,852.70 | 81.93 | 3,035.10 | 12.94 | 409 | 48.39 | 66.13 | |
591.50 | 29,861.90 | 80.45 | 4,138.46 | 22.85 | #1 5,417 | #1 3,986.36 | 42.71 | |
1,525.10 | 15,647.10 | 60.63 | 1,566.90 | 17.46 | 244 | 35.52 | 52.97 | |
1,439.00 | 9,431.00 | #1 49.93 | 1,290.20 | 17.77 | 194 | -0.88 | 37.92 | |
586.95 | 7,893.70 | 177.70 | 2,218.14 | 12.97 | 28 | -71.06 | 53.62 |
Automatic Screeners on ScanX
Forecast
Actual
Growth Rate
Revenue Growth
25.09 %
Net Income Growth
66.21 %
Cash Flow Change
-5.03 %
ROE
10.63 %
ROCE
12.64 %
EBITDA Margin (Avg.)
10.54 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 1,984 | 2,430 | 2,666 | 2,694 | 3,146 | 4,116 | 4,304 | 4,766 |
| Fixed Assets | 1,094 | 1,194 | 1,703 | 1,616 | 1,776 | 2,050 | 2,236 | 3,047 |
| Current Assets | 472 | 489 | 479 | 502 | 812 | 1,580 | 1,509 | 1,533 |
| Capital Work in Progress | 317 | 666 | 382 | 464 | 439 | 327 | 388 | 529 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 67 |
| Other Assets | 573 | 570 | 582 | 615 | 930 | 1,739 | 1,681 | 0 |
| Total Liabilities | 1,984 | 2,430 | 2,666 | 2,694 | 3,146 | 4,116 | 4,304 | 4,766 |
| Current Liabilities | 334 | 296 | 358 | 405 | 420 | 573 | 618 | 619 |
| Non Current Liabilities | 432 | 839 | 959 | 907 | 1,110 | 1,115 | 781 | 760 |
| Total Equity | 1,217 | 1,296 | 1,350 | 1,382 | 1,616 | 2,428 | 2,906 | 3,386 |
| Reserve & Surplus | 1,136 | 1,214 | 1,268 | 1,300 | 1,565 | 2,375 | 2,852 | 3,333 |
| Share Capital | 81 | 49 | 49 | 50 | 51 | 54 | 54 | 54 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Net Cash Flow | -0 | -20 | 3 | 14 | 87 | -78 | 50 | 648 | -343 |
| Investing Activities | -126 | -241 | -69 | -249 | -87 | -239 | -421 | -342 | -441 |
| Operating Activities | 213 | 228 | 63 | 166 | 175 | 242 | 311 | 645 | 612 |
| Financing Activities | -88 | -7 | 9 | 97 | -1 | -81 | 160 | 346 | -514 |
Share Holding
| % Holding | Sept 2021 | Oct 2022 | Nov 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
| Promoter | 35.04 % | 35.03 % | 33.08 % | 33.08 % | 33.08 % | 33.07 % | 33.06 % | 33.05 % | 33.04 % | 33.04 % | 33.04 % | 33.03 % | 33.03 % | 33.01 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 10.69 % | 0.00 % | 12.09 % | 12.94 % | 12.20 % | 12.47 % | 11.76 % | 11.54 % |
| DIIs | 0.00 % | 0.00 % | 7.78 % | 12.55 % | 12.35 % | 10.80 % | 10.93 % | 9.68 % | 10.25 % | 10.57 % | 11.11 % | 10.51 % | 11.93 % | 12.20 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 0.00 % | 0.00 % | 25.44 % | 6.16 % | 5.77 % | 6.79 % | 6.85 % | 6.79 % | 7.14 % | 6.28 % | 6.54 % | 6.74 % | 6.53 % | 6.48 % |
| Others | 64.96 % | 64.97 % | 33.69 % | 48.21 % | 48.80 % | 49.34 % | 38.48 % | 50.48 % | 37.47 % | 37.16 % | 37.10 % | 37.24 % | 36.75 % | 36.77 % |
| No of Share Holders | 47 | 48 | 2,86,944 | 1,21,407 | 1,07,120 | 1,09,798 | 1,16,627 | 1,24,775 | 1,66,253 | 1,55,307 | 1,49,722 | 1,48,633 | 1,54,688 | 1,56,372 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 15 May 2025 |  Quarterly Result Announcement | NA | 15 May 2025 | 1,203.60 | 1,241.80 |
| 04 Feb 2025 | Quarterly Result Announcement | NA | 04 Feb 2025 | 1,001.20 | 1,042.50 |
| 14 Nov 2024 | Quarterly Result Announcement | NA | 14 Nov 2024 | 1,073.35 | 1,032.55 |
| 19 Sept 2024 |  Annual General Meeting | NA | 19 Sept 2024 | 1,191.50 | 1,113.90 |
| 03 Aug 2024 |  Extraordinary General Meeting | NA | 03 Aug 2024 | 1,306.70 | 1,209.25 |
Announcements
Board Meeting Intimation for Intimation Under Regulation 29 Of Listing Regulations
4 hours ago
4 hours agoAnnouncement under Regulation 30 (LODR)-Allotment of ESOP / ESPS4 days ago
4 days agoIntimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations)4 days ago
4 days agoIntimation Under Regulation 30 Of The Listing Regulations.6 days ago
6 days agoIntimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Jul 11, 2025
Jul 11, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 09, 2025
Jul 09, 2025Closure of Trading WindowJun 27, 2025
Jun 27, 2025Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSJun 26, 2025
Jun 26, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 19, 2025
Jun 19, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 19, 2025
Jun 19, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 13, 2025
Jun 13, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 13, 2025
Jun 13, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 13, 2025
Jun 13, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jun 11, 2025
Jun 11, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 09, 2025
Jun 09, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 09, 2025
Jun 09, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 03, 2025
Jun 03, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 27, 2025
May 27, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 27, 2025
May 27, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 27, 2025
May 27, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 23, 2025
May 23, 2025Declaration Under Regulation 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015May 23, 2025
May 23, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 21, 2025
May 21, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 21, 2025
May 21, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 21, 2025
May 21, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 21, 2025
May 21, 2025Announcement under Regulation 30 (LODR)-Investor PresentationMay 16, 2025
May 16, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 16, 2025
May 16, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 16, 2025
May 16, 2025Key Performance Indicators (Kpis) For FY 2024-25May 15, 2025
May 15, 2025Announcement under Regulation 30 (LODR)-Investor PresentationMay 15, 2025
May 15, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 15, 2025
May 15, 2025Amendment In The Code Of Conduct Pursuant To Regulation 8 & 9 Of SEBI (Prohibition Of Insider Trading) Regulation 2015May 15, 2025
May 15, 2025Announcement under Regulation 30 (LODR)-Change in ManagementMay 15, 2025
May 15, 2025Announcement under Regulation 30 (LODR)-Dividend UpdatesMay 15, 2025
May 15, 2025Results For The Quarter And Financial Year Ended March 31 2025May 15, 2025
May 15, 2025Board Meeting Outcome for Intimation Under Regulation 30 Of SEBI Listing RegulationMay 15, 2025
May 15, 2025Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSMay 15, 2025
May 15, 2025Announcement under Regulation 30 (LODR)-Meeting UpdatesMay 15, 2025
May 15, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 09, 2025
May 09, 2025Board Meeting Intimation for Board Meeting Intimation Regarding Approval Of Financial Results For The Quarter And Financial Year Ending March 31 2025 And Recommendation Of Final Dividend.May 05, 2025
May 05, 2025Board Meeting Outcome for Intimation Under Regulation 30 Of SEBI LODR RegulationApr 28, 2025
Apr 28, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 28, 2025
Apr 28, 2025Announcement under Regulation 30 (LODR)-Meeting UpdatesApr 28, 2025
Apr 28, 2025Announcement under Regulation 30 (LODR)-Change in ManagementApr 14, 2025
Apr 14, 2025Announcement under Regulation 30 (LODR)-Change in ManagementApr 08, 2025
Apr 08, 2025Announcement under Regulation 30 (LODR)-Meeting UpdatesApr 08, 2025
Apr 08, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 07, 2025
Apr 07, 2025Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations)Apr 07, 2025
Apr 07, 2025Closure of Trading WindowMar 27, 2025
Mar 27, 2025Technical Indicators
RSI(14)
Neutral 70.28
ATR(14)
Volatile 37.34
STOCH(9,6)
Neutral 62.37
STOCH RSI(14)
Neutral 51.85
MACD(12,26)
Bullish 5.23
ADX(14)
Strong Trend 33.17
UO(9)
Bearish 48.56
ROC(12)
Uptrend And Accelerating 6.00
WillR(14)
Overbought -19.36
Mutual Fund Holdings
Invesco India Mid Cap Fund Direct-Growth 
HSBC Large and Mid Cap Fund Direct - Growth 
Canara Robeco Large and Mid Cap Fund Direct-Growth 
360 ONE FlexiCap Fund Direct - Growth 
WhiteOak Capital Pharma and Healthcare Fund Direct - Growth 
PGIM India Large and Mid Cap Fund Direct - Growth 
Nippon India Multi Asset Allocation Fund Direct - Growth 
Kotak Midcap Fund Direct-Growth 
Motilal Oswal Nifty Midcap 150 Index Fund Direct - Growth 
JM Small Cap Fund Direct - Growth 
Tata Nifty MidSmall Healthcare Index Fund Direct - Growth 
SBI Nifty Midcap 150 Index Fund Direct - Growth 
ICICI Prudential Nifty Midcap 150 Index Fund Direct - Growth 
HDFC NIFTY Midcap 150 Index Fund Direct - Growth 
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct - Growth About Global Health
Global Health Limited is a private multi-specialty tertiary care provider operating in North and East India. Founded by Dr. Naresh Trehan, the company operates under the Medanta brand with a network of 5 operational hospitals and one under construction. As of June 30, 2022, they offered healthcare services in over 30 medical specialties, employed over 1,300 doctors, and had 2,467 installed beds across 4.7 million sq. ft. of area. The company operates hospitals in Gurugram, Indore, Ranchi, Lucknow, and Patna, with specialties including cardiology, neurosciences, oncology, and orthopedics. Global Health Limited went public in November 2022, raising Rs. 2205.57 crores through an IPO. The company has been expanding its facilities, adding beds, doctors, and new medical equipment across its hospitals.
Listing Date
16 Nov, 2022(2 Years,
43 days)
Website
Chairperson NameNaresh Kumar Trehan
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
